Comparative effectiveness of digital mental healthcare models for adults with epilepsy: A study protocol of a randomized controlled trial.
anxiety
cognitive behavior therapy
depression
mood
online
Journal
Epilepsia open
ISSN: 2470-9239
Titre abrégé: Epilepsia Open
Pays: United States
ID NLM: 101692036
Informations de publication
Date de publication:
12 Feb 2024
12 Feb 2024
Historique:
received:
22
11
2023
accepted:
25
01
2024
medline:
12
2
2024
pubmed:
12
2
2024
entrez:
12
2
2024
Statut:
aheadofprint
Résumé
Mental health complaints are prevalent among people with epilepsy, yet there are major barriers that prevent access to psychological care, including high out-of-pocket costs and a lack of accessible specialized services. The purpose of the current study is to examine the comparative efficacy, acceptability, cost-effectiveness, and long-term outcomes of a digital psychological intervention when delivered under two models of care (i.e., guided vs. unguided) in supporting the mental health and functioning of adults with epilepsy. Approximately 375 participants across Australia will be enrolled. Eligible participants will have a confirmed diagnosis of epilepsy, experience difficulties with their emotional health, be at least 18 years of age, and live in Australia. Participants will be randomized (2:2:1) to receive the Wellbeing Neuro Course, a 10-week internet-delivered program, with (i.e., guided) or without guidance by a mental health clinician (i.e., unguided), or be allocated to a treatment-as-usual waiting-list control group. Participants will complete online questionnaires at pre-, post-treatment, and 3- and 12-month follow-up and consent to have their data linked to their medical records to capture healthcare system resource use and costs. Primary outcome measures will be symptoms of depression and anxiety. A cost-utility analysis will be undertaken using the Australian healthcare system perspective and according to current economic evaluation guidelines. Resource use and costs to the healthcare system during the study period will be captured via data linkage to relevant administrative datasets in Australia. The results of this trial will provide important data concerning the relative outcomes of these different models of care and will inform the integration of digital psychological interventions translation into healthcare services. The Human Research Ethics Committee of Macquarie University approved the proposed study (Reference No: 520231325151475). The results will be disseminated through peer-reviewed publication(s). ACTRN12623001327673. This study seeks to find out if a 10-week online psychological treatment can improve the mental health and well-being of Australian adults with epilepsy. Around 375 participants will be randomly assigned to different groups: one will receive treatment with guidance from mental health clinician (guided group), one without guidance (unguided group), and one starting later (waiting control group). All participants will fill out the same outcome measures online. The main goal of this research is to compare these groups and assess how well the treatment works in improving mental health outcomes.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : National Health and Medical Research Council
ID : MRFF 2022157
Informations de copyright
© 2024 The Authors. Epilepsia Open published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.
Références
Mula M, Kanner AM, Jetté N, Sander JW. Psychiatric comorbidities in people with epilepsy. Neurol Clin Pract. 2021;11:e112-e120.
Mindgardens Neurosicence Network. Review of the burden of disease for neurological, mental health and substance use disorders in Australia. 2019. https://www.mindgardens.org.au/wp-content/uploads/2019/03/MINDGARDENS-WHITE-PAPER-FINAL-14th-March-2019.pdf
Patel V, Chisholm D, Parikh R, Charlson FJ, Degenhardt L, Dua T, et al. Addressing the burden of mental, neurological, and substance use disorders: key messages from disease control priorities, 3rd edition. Lancet. 2016;387:1672-1685.
Mula M, Coleman H, Wilson SJ. Neuropsychiatric and cognitive comorbidities in epilepsy. Continuum (Minneap Minn). 2022;28:457-482.
Taylor RS, Sander JW, Taylor RJ, Baker GA. Predictors of health-related quality of life and costs in adults with epilepsy: a systematic review. Epilepsia. 2011;52:2168-2180. https://doi.org/10.1111/j.1528-1167.2011.03213.x
Kwan P, Yu E, Leung H, Leon T, Mychaskiw MA. Association of subjective anxiety, depression, and sleep disturbance with quality-of-life ratings in adults with epilepsy. Epilepsia. 2009;50:1059-1066. https://doi.org/10.1111/j.1528-1167.2008.01938.x
Global actions on epilepsy and other neurological disorders [database on the internet]. SEVENTY-THIRD WORLD HEALTH ASSEMBLY 2020 Available from: https://apps.who.int/gb/ebwha/pdf_files/WHA73/A73_R10-en.pdf
Michaelis R, Tang V, Nevitt SJ, Wagner JL, Modi AC, LaFrance W Jr, et al. Psychological treatments for people with epilepsy Cochrane database of systematic reviews. 2020.
Gandy M, Sharpe L, Perry KN. Cognitive behavior therapy for depression in people with epilepsy: a systematic review. Epilepsia. 2013;54:1725-1734.
Gandy M, Modi AC, Wagner JL, LaFrance WC Jr, Reuber M, Tang V, et al. Managing depression and anxiety in people with epilepsy: a survey of epilepsy health professionals by the ILAE Psychology Task Force. Epilepsia Open. 2021;6:127-139. https://doi.org/10.1002/epi4.12455
Marco M, Esper C, Alla G, Andres MK, Hyang Woon L, Çiğdem Ö, et al. Educational needs of epileptologists regarding psychiatric comorbidities of the epilepsies: a descriptive quantitative survey. Epileptic Disord. 2017;19:178-185.
Hermann B, Loring DW, Wilson S. Paradigm shifts in the neuropsychology of epilepsy. J Int Neuropsychol Soc. 2017;23:791-805.
Gandy M, Karin E, Fogliati VJ, Meares S, Nielssen O, Titov N, et al. Emotional and cognitive difficulties, help-seeking, and barriers to treatment in neurological disorders. Rehabil Psychol. 2018;63:563-574.
Gandy M, Sharpe L, Nicholson Perry K, Thayer Z, Miller L, Boserio J, et al. Cognitive behaviour therapy to improve mood in people with epilepsy: a randomised controlled trial. Cogn Behav Ther. 2014;43:153-166.
Andersson G, Titov N, Dear BF, Rozental A, Carlbring P. Internet-delivered psychological treatments: from innovation to implementation. World Psychiatry. 2019;18:20-28.
Carlbring P, Andersson G, Cuijpers P, Riper H, Hedman-Lagerlöf E. Internet-based vs. face-to-face cognitive behavior therapy for psychiatric and somatic disorders: an updated systematic review and meta-analysis. Cogn Behav Ther. 2018;47:1-18.
Titov N, Dear BF, Nielssen O, Wootton B, Kayrouz R, Karin E, et al. User characteristics and outcomes from a national digital mental health service: an observational study of registrants of the Australian MindSpot Clinic. Lancet Digital Health. 2020;2:e582-e593.
Bogosian A, Hurt CS, Hindle JV, McCracken LM, Vasconcelos e Sa DA, Axell S, et al. Acceptability and feasibility of a mindfulness intervention delivered via videoconferencing for people with Parkinson's. J Geriatr Psychiatry Neurol. 2022;35:155-167.
Dobkin RD, Mann SL, Weintraub D, Rodriguez KM, Miller RB, St. Hill L, et al. Innovating Parkinson's care: a randomized controlled trial of telemedicine depression treatment. Mov Disord. 2021;36:2549-2558.
Boeschoten RE, Dekker J, Uitdehaag BM, Beekman AT, Hoogendoorn AW, Collette EH, et al. Internet-based treatment for depression in multiple sclerosis: a randomized controlled trial. Mult Scler J. 2017;23:1112-1122.
Fischer A, Schröder J, Vettorazzi E, Wolf OT, Pöttgen J, Lau S, et al. An online programme to reduce depression in patients with multiple sclerosis: a randomised controlled trial. Lancet Psychiatry. 2015;2:217-223.
Gold SM, Friede T, Meyer B, Moss-Morris R, Hudson J, Asseyer S, et al. Internet-delivered cognitive behavioural therapy programme to reduce depressive symptoms in patients with multiple sclerosis: a multicentre, randomised, controlled, phase 3 trial. Lancet Digital Health. 2023;5:e668-e678.
Bromberg J, Wood ME, Black RA, Surette DA, Zacharoff KL, Chiauzzi EJ. A randomized trial of a web-based intervention to improve migraine self-management and coping. Headache. 2012;52:244-261.
Schröder J, Brückner K, Fischer A, Lindenau M, Köther U, Vettorazzi E, et al. Efficacy of a psychological online intervention for depression in people with epilepsy: a randomized controlled trial. Epilepsia. 2014;55:2069-2076.
Meyer B, Weiss M, Holtkamp M, Arnold S, Brückner K, Schröder J, et al. Effects of an epilepsy-specific internet intervention (Emyna) on depression: results of the ENCODE randomized controlled trial. Epilepsia. 2019;60:656-668.
Krieger T, Bur OT, Weber L, Wolf M, Berger T, Watzke B, et al. Human contact in internet-based interventions for depression: a pre-registered replication and meta-analysis of randomized trials. Internet Interv. 2023;32:100617.
Gandy M, Pang STY, Scott AJ, Heriseanu AI, Bisby MA, Dudeney J, et al. Internet-delivered cognitive and behavioural based interventions for adults with chronic pain: a systematic review and meta-analysis of randomized controlled trials. Pain. 2022;163:e1041-e1053.
Karyotaki E, Efthimiou O, Miguel C, Bermpohl FMG, Furukawa TA, Cuijpers P, et al. Internet-based cognitive behavioral therapy for depression: a systematic review and individual patient data network meta-analysis. JAMA Psychiatry. 2021;78:361-371.
Dear BF, Karin E, Fogliati R, Dudeney J, Nielssen O, Scott AJ, et al. A cost-effectiveness analysis of an internet-delivered pain management program delivered with different levels of clinician support: results from a randomised controlled trial. J Pain. 2021;22:344-358.
Gandy M, Karin E, Fogliati VJ, McDonald S, Titov N, Dear BF. A feasibility trial of an Internet-delivered and transdiagnostic cognitive behavioral therapy treatment program for anxiety, depression, and disability among adults with epilepsy. Epilepsia. 2016;57:1887-1896.
Gandy M, Karin E, McDonald S, Meares S, Scott AJ, Titov N, et al. A feasibility trial of an internet-delivered psychological intervention to manage mental health and functional outcomes in neurological disorders. J Psychosom Res. 2020;136:110173.
Gandy M, Heriseanu AI, Balakumar T, Karin E, Walker J, Hathway T, et al. The wellbeing neuro course: a randomised controlled trial of an internet-delivered transdiagnostic psychological intervention for adults with neurological disorders. Psychol Med. 2023;53:1-11.
First MB, Williams JB. Quick structured clinical interview for DSM-5® disorders (QuickSCID-5). Washington, DC: American Psychiatric Association Publishing; 2022.
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606-613.
Löwe B, Decker O, Müller S, Brähler E, Schellberg D, Herzog W, et al. Validation and standardization of the generalized anxiety disorder screener (GAD-7) in the general population. Med Care. 2008;46:266-274.
Üstün TB, Chatterji S, Kostanjsek N, Rehm J, Kennedy C, Epping-Jordan J, et al. Developing the World Health Organization Disability Assessment Schedule 2.0. Bulletin of the World Health Organization. 2010;88:815-823. doi:10.2471/blt.09.067231
Cella D, Lai JS, Nowinski CJ, Victorson D, Peterman A, Miller D, et al. Neuro-QOL: brief measures of health-related quality of life for clinical research in neurology. Neurology. 2012;78:1860-1867.
Gilliam FG, Barry JJ, Hermann BP, Meador KJ, Vahle V, Kanner AM. Rapid detection of major depression in epilepsy: a multicentre study. Lancet Neurol. 2006;5:399-405.
Scott AJ, Sharpe L, Thayer Z, Miller LA, Hunt C, MacCann C, et al. Design and validation of two measures to detect anxiety disorders in epilepsy: the epilepsy anxiety survey instrument and its brief counterpart. Epilepsia. 2019;60:2068-2077.
Keetharuth AD, Brazier J, Connell J, Bjorner JB, Carlton J, Taylor Buck E, et al. Recovering quality of life (ReQoL): a new generic self-reported outcome measure for use with people experiencing mental health difficulties. Br J Psychiatry. 2018;212:42-49.
Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20:1727-1736.
Timman R, Bouwmans C, Busschbach JJV, Hakkaart-van RL. Development of the treatment inventory of costs in psychiatric patients: TIC-P mini and Midi. Value Health. 2015;18:994-999.
Cook JA, Julious SA, Sones W, Hampson LV, Hewitt C, Berlin JA, et al. DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial. BMJ. 2018;363:k3750.
Donohue MC, Gamst AC, Edland SD, Donohue MMC. Package ‘longpower’. Biometrics. 2013;53:937-947.
Karin E, Crane MF, Dear BF, Nielssen O, Heller GZ, Kayrouz R, et al. Predictors, outcomes, and statistical solutions of missing cases in web-based psychotherapy: methodological replication and elaboration study. JMIR Ment Health. 2021;8:e22700.
Karin E, Dear BF, Heller GZ, Crane MF, Titov N. “Wish you were here”: examining characteristics, outcomes, and statistical solutions for missing cases in web-based psychotherapeutic trials. JMIR Ment Health. 2018;5:e22.
Greene CJ, Morland LA, Durkalski VL, Frueh BC. Noninferiority and equivalence designs: issues and implications for mental health research. J Trauma Stress. 2008;21:433-439.
Malehi AS, Pourmotahari F, Angali KA. Statistical models for the analysis of skewed healthcare cost data: a simulation study health economics. Review. 2015;5:11.
Edney LC, Haji Ali Afzali H, Cheng TC, Karnon J. Estimating the reference incremental cost-effectiveness ratio for the Australian health system. PharmacoEconomics. 2018;36:239-252.
Ramsey SD, Willke RJ, Glick H, Reed SD, Augustovski F, Jonsson B, et al. Cost-effectiveness analysis alongside clinical trials II-an ISPOR good research practices task force report. Value Health. 2015;18:161-172.
Husereau D, Drummond M, Augustovski F, de Bekker-Grob E, Briggs AH, Carswell C, et al. Consolidated health economic evaluation reporting standards (CHEERS) 2022 explanation and elaboration: a report of the ISPOR CHEERS II good practices task force. Value Health. 2022;25:10-31.